Literature DB >> 15982339

The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.

Paul Harrison1.   

Abstract

The PFA-100 provides a simple global measure of high shear-dependent platelet function, and as such is not diagnostic or specific to any disorder. Prolonged closure times must be interpreted in conjunction with a full blood count, von Willebrand factor (VWF) screen and other platelet tests. The PFA-100 may also give false negative results with relatively common platelet defects. If clinical suspicion is high, further detailed platelet function testing and VWF screening are required to exclude abnormal platelet function, even if the PFA-100 is normal. In more recent studies the PFA-100 has been used for preoperative identification and management of surgical patients with haemostatic defects and for assessing the clinical effectiveness of platelet transfusion therapy. This review highlights the up to date, evidence-based, advantages and disadvantages of the PFA-100 test in the investigation and management of haemostatic disorders in both children and adults.

Entities:  

Mesh:

Year:  2005        PMID: 15982339     DOI: 10.1111/j.1365-2141.2005.05511.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

Review 1.  Blood biomarkers of ischemic stroke.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 2.  Making a diagnosis of VWD.

Authors:  Brian R Branchford; Jorge Di Paola
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 3.  Management of coagulopathy in the setting of acute neurosurgical disease and injury.

Authors:  Marlon Mathews; Richard Newman; E Thomas Chappell
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system.

Authors:  Giuseppe Scrascia; Crescenzia Rotunno; Piero Guida; Manuela Conte; Lillà Amorese; Vito Margari; Luigi de Luca Tupputi Schinosa; Domenico Paparella
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-18

5.  Anti-platelet Therapy Resistance - Concept, Mechanisms and Platelet Function Tests in Intensive Care Facilities.

Authors:  Alina Mărginean; Claudia Bănescu; Alina Scridon; Minodora Dobreanu
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

Review 6.  How do you treat bleeding disorders with desmopressin?

Authors:  Bülent Ozgönenel; Madhvi Rajpurkar; Jeanne M Lusher
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

7.  Label-free multimodal quantitative imaging flow assay for intrathrombus formation in vitro.

Authors:  Yujie Zheng; Samantha J Montague; Yean J Lim; Tao Xu; Tienan Xu; Elizabeth E Gardiner; Woei Ming Lee
Journal:  Biophys J       Date:  2021-01-26       Impact factor: 4.033

8.  Dynamic analysis of platelet deposition to resolve platelet adhesion receptor activity in whole blood at arterial shear rate.

Authors:  Nicholas Pugh; Dominique Bihan; David J Perry; Richard W Farndale
Journal:  Platelets       Date:  2014-03-28       Impact factor: 3.862

9.  Assays of different aspects of haemostasis - what do they measure?

Authors:  Nahreen Tynngård; Tomas L Lindahl; Sofia Ramström
Journal:  Thromb J       Date:  2015-02-05

10.  The Platelet Function Analyzer (PFA-100) as a Screening Tool in Neurosurgery.

Authors:  Ralf Karger; Karoline Reuter; Jochen Rohlfs; Christopher Nimsky; Ulrich Sure; Volker Kretschmer
Journal:  ISRN Hematol       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.